Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cancer Therapies02:49

Cancer Therapies

7.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.6K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.5K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

5.7K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.7K
Tumor Immunotherapy01:27

Tumor Immunotherapy

514
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
514

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Regulation of lineage reprogramming by dynamic chromatin SUMOylation.

Cellular and molecular life sciences : CMLS·2026
Same author

An adipocyte-endothelial framework to identify molecular signatures of metabolic vulnerability in obesity.

Research square·2026
Same author

ADAR1 and ADAR2 associate with the RNA exosome and modulate RNA stability.

Nucleic acids research·2026
Same author

Risk Haplotype of BTNL2 Predisposes Male Patients to NSTEMI: A Genetic and Functional Study.

Research square·2026
Same author

Innate Immune Evasion of Lyme Disease Pathogen Drives Alzheimer-Like Pathology.

Research square·2026
Same author

Recruitment of bifunctional regulator thermospermine to methylated ribosomes directs xylem fate.

Science (New York, N.Y.)·2026

Related Experiment Video

Updated: Jun 24, 2025

Oncogenic Gene Fusion Detection Using Anchored Multiplex Polymerase Chain Reaction Followed by Next Generation Sequencing
09:49

Oncogenic Gene Fusion Detection Using Anchored Multiplex Polymerase Chain Reaction Followed by Next Generation Sequencing

Published on: July 5, 2019

9.5K

Oncofusions - shaping cancer care.

Giovanna Dashi1,2, Markku Varjosalo1,2

  • 1Institute of Biotechnology, HiLIFE Helsinki Institute of Life Science, University of Helsinki, Helsinki, Finland.

The Oncologist
|June 4, 2024
PubMed
Summary

Oncofusions, a type of gene fusion in cancer, drive tumor growth through genomic rearrangements. Identifying and targeting these oncofusions offers promising therapeutic strategies for precision medicine.

More Related Videos

Microfluidic Co-Culture Models for Dissecting the Immune Response in in vitro Tumor Microenvironments
07:46

Microfluidic Co-Culture Models for Dissecting the Immune Response in in vitro Tumor Microenvironments

Published on: April 30, 2021

4.7K
Three-dimensional Co-culture Model for Tumor-stromal Interaction
08:39

Three-dimensional Co-culture Model for Tumor-stromal Interaction

Published on: February 2, 2015

17.4K

Related Experiment Videos

Last Updated: Jun 24, 2025

Oncogenic Gene Fusion Detection Using Anchored Multiplex Polymerase Chain Reaction Followed by Next Generation Sequencing
09:49

Oncogenic Gene Fusion Detection Using Anchored Multiplex Polymerase Chain Reaction Followed by Next Generation Sequencing

Published on: July 5, 2019

9.5K
Microfluidic Co-Culture Models for Dissecting the Immune Response in in vitro Tumor Microenvironments
07:46

Microfluidic Co-Culture Models for Dissecting the Immune Response in in vitro Tumor Microenvironments

Published on: April 30, 2021

4.7K
Three-dimensional Co-culture Model for Tumor-stromal Interaction
08:39

Three-dimensional Co-culture Model for Tumor-stromal Interaction

Published on: February 2, 2015

17.4K

Area of Science:

  • Genomic alterations in oncology
  • Cancer genomics and structural variations

Background:

  • Cancer development involves diverse mutations, including oncofusions.
  • Oncofusions are structural genetic alterations that play a role in tumorigenesis.
  • Examples like BCR::ABL and EWS::FLI1 highlight their clinical importance.

Purpose of the Study:

  • To explore the role of oncofusions in cancer development and progression.
  • To emphasize the clinical significance of identifying and targeting oncofusions.
  • To discuss challenges and future directions in oncofusion research for precision medicine.

Main Methods:

  • Analysis of genomic rearrangements leading to oncofusion formation.
  • Review of case studies demonstrating the impact of oncofusion identification.
  • Integration of genomics, functional studies, and drug discovery approaches.

Main Results:

  • Oncofusions arise from genomic rearrangements, causing deregulation or hybrid genes.
  • Identification of oncofusions can guide treatment decisions and improve patient outcomes.
  • Challenges include distinguishing driver from passenger mutations and overcoming resistance.

Conclusions:

  • Oncofusions are significant drivers in various cancers.
  • Targeting oncofusions holds potential for precision cancer therapy.
  • Further multidisciplinary research is needed to fully exploit oncofusions as therapeutic targets.